GCLC and lung carcinoma: Treatment of ABC1 and SW900 lung cancer cells, which both contain a functional KEAP1-NRF2 response, resulted in significant induction of NRF2 target gene expression, including NQO1, GCLC, HMOX1 and TXNRD1 (Fig. 1c, d).